Global Cost Effective Analysis Of Apixaban Versus Warfarin For The Prevention Of Stroke As A Result Of Atrial Fibrillation- A Systematic Review
May 1, 2018, 00:00
10.1016/j.jval.2018.04.372
https://www.valueinhealthjournal.com/article/S1098-3015(18)30672-7/fulltext
Title :
Global Cost Effective Analysis Of Apixaban Versus Warfarin For The Prevention Of Stroke As A Result Of Atrial Fibrillation- A Systematic Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30672-7&doi=10.1016/j.jval.2018.04.372
First page :
Section Title :
Open access? :
No
Section Order :
1230